SCHEMBL6739125

SCHEMBL6739125

CCOC(=O)c1cc2c(C)c(C)ccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.58
▸ ALDH1A1 P00352 7/20 0.58
▸ RAB9A P51151 7/20 0.58
▸ HPGD P15428 5/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ HCRTR1 O43613 2/20 0.57
▸ NPC1 O15118 5/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HTT P42858 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ HRH3 Q9Y5N1 1/20 0.55
▸ MAPT P10636 4/20 0.54
▸ GAA P10253 3/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ GLA P06280 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ MMP13 P45452 6/20 0.53
▸ MMP2 P08253 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5780732 0.85 KDM4E (0.56) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL5622542 0.85 KDM4E (0.56) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL7954222 0.85 ALOX15 (0.57) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL19332451 0.85 ALOX15 (0.57) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL17429439 0.85 KDM4E (0.56) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL3606511 0.84 RAB9A (0.50) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL13684586 0.84 KDM4E (0.55) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL2015917 0.84 KDM4E (0.58) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL701020 0.82 KDM4E (0.57) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2
SCHEMBL7325236 0.81 ALDH1A1 (0.56) KDM4EALDH1A1RAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040043995-A1 Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them BIGNON ERIC (FR) 2004-03-04 — — US disclosed
CN-1263528-A N-triazolyl-2-indolecarboxamides and their use in CCK-A agonists SANOFI SYNTHELABO (FR) 2000-08-16 — — CN disclosed
US-4060626-A Indole-carboxylic carbon compounds and pharmaceutical compositions containing them BOEHRINGER MANNHEIM G.M.B.H. (DT) 1977-11-29 — — US disclosed
US-3996241-A 2-Hydroxymethyl indole compounds and blood sugar lowering compositions BOEHRINGER MANNHEIM G.M.B.H. (DT) 1976-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043995-A1 Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them CCKAR, CCKBR, NPY1R KDM4E 1971/4885ALDH1A1 2097/4885RAB9A 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback